Pds biotech to host clinical program update conference call on august 1, 2024, at 8 a.m. eastern time

Princeton, n.j., july 31, 2024 (globe newswire) -- pds biotechnology corporation (nasdaq: pdsb) (“pds biotech” or the “company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers and the development of infectious disease vaccines, today announced that the company will host a conference call to provide a clinical program update on thursday, august 1, 2024, at 8:00 a.m. et.
PDSB Ratings Summary
PDSB Quant Ranking